Ground News

See every side of every news story

FDA image

News about FDA

Stay current with all the latest and breaking news about FDA, compare headlines and perspectives between news sources on stories happening today. In total, 559stories have been published about FDA which Ground News has aggregated in the past 3 months.

Covered Most By

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top FDA News

Top FDA Vaccine Official Rejected Broad Use of Covid-19 Shots, Documents Show

FDA · United States

Top FDA Vaccine Official Rejected Broad Use of Covid-19 Shots, Documents Show

79% Center coverage: 130 sources

KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease

Pharma · United States

KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease

86% Center coverage: 7 sources

KalVista Pharmaceuticals’ Ekterly is now FDA approved for treating acute swelling attacks from hereditary angioedema. The KalVista tablet provides an alternative to injectable or infused HAE medications from companies such as Takeda Pharmaceutical and CSL Behring. The post KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease appeared first on MedCity News.See the Story

Khosla Ventures Targets Nearly $4 Billion in New Funds

FDA · United States

Khosla Ventures Targets Nearly $4 Billion in New Funds

75% Center coverage: 4 sources

KalVista has brought the first oral, on-demand treatment for hereditary angioedema attacks to the US market See the Story

Blindspots

RNA-Seq Analysis of Human Heart Tissue Reveals SARS-CoV-2 Infection and Inappropriate Activation of the TNF-NF-κB Pathway in Cardiomyocytes

Prediction of Population Behavior of Listeria Monocytogenes in Food Using Machine Learning and a Microbial Growth and Survival Database

100% Center coverage: 1 sources

In predictive microbiology, statistical models are employed to predict bacterial population behavior in food using environmental factors such as temperature, pH, and water activity. As the amount and complexity of data increase, handling all data with high-dimensional variables becomes a difficult task. We propose a data mining approach to predict bacterial behavior using a database of microbial responses to food environments. Listeria monocytog…Oscar Mayer See the Story

ALS Community Files Citizens’ Petition asking FDA to Approve NurOwn Stem Cell Therapy

100% Left coverage: 1 sources

New and Unprecedented Survival, Respiratory, and Biomarker Data ProveWeatherford · Weatherford Read Article

FDA Expands Label for GE HealthCare’s Vizamyl PET Agent to Aid Alzheimer’s Diagnostics

The U.S. Food and Drug Administration (FDA) has approve […] The post FDA Expands Label for GE HealthCare’s Vizamyl PET Agent to Aid Alzheimer’s Diagnostics first appeared on GeneOnline News. The post FDA Expands Label for GE HealthCare’s Vizamyl PET Agent to Aid Alzheimer’s Diagnostics appeared first on GeneOnline News.FDA · United States Read Article

High Levels of Arsenic Discovered in US Rice

100% Right coverage: 1 sources

by Dr. Joseph Mercola, Mercola: Story at-a-glance More than 1 in 4 rice products sold in the U.S. now exceed the FDA’s arsenic limit for infant cereal, exposing families to heavy metals that harm brain development, kidneys, and long-term health Brown rice grown in the southeastern U.S. was the most contaminated, while white basmati from […]FDA · United States Read Article

Animal Testing Under REACH: It’s Time to Take “Last Resort” Seriously

100% Left coverage: 1 sources

The European legal framework requires its Member States to pay full regard to animal welfare standards when formulating and implementing policies. Yet, when it comes to chemical safety, the EU’s flagship regulation, REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals), still relies heavily on animal testing, despite its stated commitment to making this a “last resort.”Animal Testing See the Story

Cogent Reports Positive Topline Results From SUMMIT Trial of Bezuclastinib in NonAdvSM - BioTuesdays

Cogent Biosciences (NASDAQ: COGT) has announced positive topline results from the SUMMIT trial of bezuclastinib in patients with non-advanced systemic mastocytosis (NonAdvSM), achieving statistical significance across all primary and secondary endpoints. According to Cogent, based on these results, the company is on track to submit its first new drug application (NDA) to the FDA for bezuclastinib in NonAdvSM by the end of 2025. Additionally, Cog…FDA · Denver See the Story

Cambodia 2nd Asian Country to Rollout Long-Acting Injectable HIV Prevention Option - Daily Good Morning Kashmir

Open the article to view the coverage from dailygoodmorningkashmir.comFDA · United States See the Story

FDA Requires New Warning on mRNA COVID Shots Due to Heart Damage in Young Men

100% Right coverage: 1 sources

From LifeSiteNews By Doug Mainwaring Pfizer and Moderna’s mRNA COVID shots must now include warnings that they cause ‘extremely high risk’ of heart inflammation and irreversible damage in males up to age 24. The Trump administration’s Food and Drug Administration (FDA) announced it will now require updated safety warnings on mRNA COVID-19 shots to include the “extremely high risk” of myocarditis/pericarditis and the likelihood of long-term, irr…Coronavirus · Norway See the Story

Breaking News Topics Related to FDA